AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

Clinical trial NCT04895215 · COMPLETED

Trial details

NCT number: NCT04895215
Sponsor: Vertero Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder (ASD)

Start date: 2021-08-02
Primary completion: 2023-11-15
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.